Phase II Interventional Study Evaluating Efficacy and Safety of Secukinumab in Active Severe Takayasu Patients
Clinical trial NCT07477795 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07477795
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2029-10-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.